WHO warns of Asian tuberculosis threat
This article was originally published in Scrip
The World Health Organizationhas again highlighted the global health threat posed by the growing incidence of multidrug-resistant tuberculosis (MDR-TB), for which Asia has emerged as a particular trouble spot.
You may also be interested in...
Positive clinical results in Parkinson’s pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.